<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">12799630</PMID>
        <DateCompleted>
            <Year>2003</Year>
            <Month>08</Month>
            <Day>08</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0007-0920</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>88</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2003</Year>
                        <Month>Jun</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>British journal of cancer</Title>
                <ISOAbbreviation>Br. J. Cancer</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1878-82</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Serum protein induced by vitamin K absence or antagonist II (PIVKAII), hepatoma-specific band of serum gamma-glutamyl transferase (GGTII), and alpha-fetoprotein (AFP) levels were determined in 120 patients with hepatocellular carcinoma (HCC) and 90 patients with cirrhosis. The mean serum concentration of PIVKAII in HCC patients was higher than that in cirrhotic patients. A total of 53.3% of patients (64 out of 120) with HCC had PIVKAII levels above 40 mAU ml(-1). However, only 13 patients with cirrhosis had higher PIVKA II levels. Of 32 small HCC patients, 13 (40.6%) had PIVKAII values above 40 mAU ml(-1). An increased concentration of AFP (i.e. 20 ng ml(-1)) was observed in 70 out of 120 (58.3%) patients with HCC and in 33 out of 90 (36.7%) patients with cirrhosis. Positive GGTII was found in 74.0% (89 out of 120) cases of HCC (sensitivity), in 16 of 90 cases of cirrhosis, and 14 of 32 (43.8%) small HCC patients had GGTII positive. No significant correlation was found between serum levels of AFP and PIVKAII. Combining the information from PIVKAII, AFP, and GGTII significantly increases the sensitivity over AFP alone. PIVKAII and GGTII are useful tumour markers complementary to AFP for diagnosis of HCC.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cui</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Liver Research Center, Beijing Friendship Hospital, Capital University of Medical Science, Beijing 100050, China. cuirutao@iarc.fr</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>X</ForeName>
                    <Initials>X</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D023362">Evaluation Studies</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Br J Cancer</MedlineTA>
            <NlmUniqueID>0370635</NlmUniqueID>
            <ISSNLinking>0007-0920</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>53230-14-1</RegistryNumber>
                <NameOfSubstance UI="C008208">acarboxyprothrombin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>9001-26-7</RegistryNumber>
                <NameOfSubstance UI="D011516">Prothrombin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.3.2.2</RegistryNumber>
                <NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011516" MajorTopicYN="N">Prothrombin</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName>
                <QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2003</Year>
                <Month>6</Month>
                <Day>12</Day>
                <Hour>5</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2003</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>5</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2003</Year>
                <Month>6</Month>
                <Day>12</Day>
                <Hour>5</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">12799630</ArticleId>
            <ArticleId IdType="doi">10.1038/sj.bjc.6601018</ArticleId>
            <ArticleId IdType="pii">6601018</ArticleId>
            <ArticleId IdType="pmc">PMC2741121</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Gastroenterol. 2000 Apr;95(4):1036-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10763956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 1965 Feb;11:118-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14292072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 1967 Mar;15(3):387-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6034415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 1975 Aug 4;62(3):425-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">240517</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 1980 Sep 25;106(2):165-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6157503</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterol Jpn. 1981;16(2):122-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6112191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1983 Jan 15;51(2):327-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6185200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1984 May 31;310(22):1427-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6201741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gan. 1984 Apr;75(4):301-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6145647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 1984 Oct;50(4):451-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6207851</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 1985 Dec 15;36(6):667-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2415467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1986 Jul-Aug;6(4):729-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2426173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 1987 Jun;4(3):357-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3036940</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1988 Apr 15;61(8):1621-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2450634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 1990 Aug;99(2):508-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1694805</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 1992 Aug;87(8):991-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1353662</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1993 Jun 24;328(25):1802-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7684823</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1994 May 15;73(10):2464-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7513601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1994 Dec 1;74(11):2918-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7525036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liver. 1995 Oct;15(5):260-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8531596</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1996 May 1;77(9):1781-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8646674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol. 1997 Aug;32(4):507-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9250899</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transpl Int. 1998;11(2):143-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9561681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1998 May 1;82(9):1643-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9576283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Pathol. 1998 Dec;110(6):743-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9844586</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Gastroenterol. 1999 Mar;94(3):650-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10086646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1999 Feb 15;85(4):812-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10091758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin Med J (Engl). 2002 Jan;115(1):42-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11930656</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>